ROLE OF PREOPERATIVE RADIATION THERAPY IN COMBINED TREATMENT OF RESECTABLE RECTAL CANCER

dc.contributor.author	Davronov B.A
dc.contributor.author	Ulmasov F.G
dc.contributor.author	Sharipova N.Y
dc.date.accessioned	2025-12-31T15:38:26Z
dc.date.issued	2024-01-14
dc.description.abstract	Colorectal cancer is one of the most common cancers in the world. In the Russian Federation, about 40 thousand new cases of the disease are registered annually. Five-year survival rate for rectal cancer depends on the stage of the disease and ranges from 50% for stage I to 20% for stage IV. Currently, combined treatment with radiation therapy is the standard of care for resectable rectal cancer. Radiation therapy can reduce the size of the tumor, which facilitates surgery, and reduces the risk of local recurrence of the disease.
dc.format	application/pdf
dc.identifier.uri	https://scholarexpress.net/index.php/wbph/article/view/3644
dc.identifier.uri	https://asianeducationindex.com/handle/123456789/49584
dc.language.iso	eng
dc.publisher	Scholar Express Journals
dc.relation	https://scholarexpress.net/index.php/wbph/article/view/3644/3100
dc.rights	https://creativecommons.org/licenses/by-nc-nd/4.0
dc.source	World Bulletin of Public Health; Vol. 30 (2024): WBPH; 20-22
dc.source	2749-3644
dc.subject	disease
dc.subject	common
dc.subject	standard
dc.subject	therapy
dc.title	ROLE OF PREOPERATIVE RADIATION THERAPY IN COMBINED TREATMENT OF RESECTABLE RECTAL CANCER
dc.type	info:eu-repo/semantics/article
dc.type	info:eu-repo/semantics/publishedVersion
dc.type	Peer-reviewed Article

item.page.files

pagination.showing.labelpagination.showing.detail

item.page.filesection.name: ba_2024_role_of_preoperative_radiation_therapy_i.pdf
item.page.filesection.size: 151.5 KB
item.page.filesection.format: Adobe Portable Document Format